Patents by Inventor Vincent Miller
Vincent Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240392378Abstract: Methods and compositions for treating cancer such as melanomas are disclosed.Type: ApplicationFiled: June 22, 2023Publication date: November 28, 2024Applicants: Foundation Medicine, Inc., Vanderbilt UniversityInventors: Garrett Michael FRAMPTON, Roman YELENSKY, James Xin SUN, Douglas Buckner JOHNSON, Christine Marie LOVLY, Jeffrey Alan SOSMAN, David FABRIZIO, Philip James STEPHENS, Vincent A. MILLER
-
Patent number: 12116638Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: GrantFiled: February 16, 2022Date of Patent: October 15, 2024Assignee: Foundation Medicine, Inc.Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Patent number: 12087453Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.Type: GrantFiled: August 10, 2022Date of Patent: September 10, 2024Assignee: Foundation Medicine, Inc.Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20240289336Abstract: Aspects of the present disclosure relate to ingesting event data into a discoverable event stream using a common schema to assign timeseries properties to the event data. These techniques may include receiving a first event of a pre-processed event stream, the first event including a plurality of event data fields representing an occurrence of the first event, and determining timing information based on the plurality of event data fields representing the occurrence of the first event. In addition, the techniques may include generating, based on combining the plurality of event data fields and the timing information, a second event of a discoverable event stream corresponding to the pre-processed event stream, and generating, within a time series of the discoverable event stream, based on the timing information and an event field of the plurality of event data fields, a time series entry corresponding to the second event.Type: ApplicationFiled: June 9, 2023Publication date: August 29, 2024Inventors: Abhilash PANWAR, Clemens Alden SZYPERSKI, Florin-Cristian DIACONESCU, Eddy LeRoy MILLER, Giorgos GAVRIIL, Hadrian LIM WEI HENG, James Douglas HUTTON, Jan Richard HERKELRATH, Jianyu ZHAO, John Te-Jui SHEU, Jakub SAKOWICZ, Luca COLANTONIO, Mason Collin PINE, Maxim KIRYUSHIN, Miquel MARTIN LOPEZ, Niall Vincent EGAN, Nuno Jose Pinto Bessa DE MELO CERQUEIRA, Pawel Mateusz CHODARCEWICZ, Phanidhar GOPAVARAM, Rony Alex THOMAS, Santosh BALASUBRAMANIAN, William Charles THOMPSON, Muthubharathi PERIANNAN
-
Publication number: 20240241388Abstract: In some implementations, a dot projector optic may include a collimating lens; a fisheye lens; and a dot aberration correction element disposed between the collimating lens and the fisheye lens. An input to the fisheye lens, from the dot aberration correction element, may be associated with a first field of view angle. An output from the fisheye lens may be associated with a second field of view angle that is larger than the first field of view angle.Type: ApplicationFiled: March 17, 2023Publication date: July 18, 2024Inventors: James CHEN, Michael MILLER, Lijun ZHU, Vincent V. WONG, Russell Latham, Benjamin KESLER
-
Publication number: 20230372338Abstract: Methods and compositions for treating cholangiocarcinoma.Type: ApplicationFiled: June 30, 2023Publication date: November 23, 2023Applicant: Foundation Medicine, Inc.Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
-
Patent number: 11771698Abstract: Methods and compositions for treating cholangiocarcinoma.Type: GrantFiled: March 17, 2021Date of Patent: October 3, 2023Assignee: Foundation Medicine, Inc.Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
-
Patent number: 11725247Abstract: Methods and compositions for treating cancer such as melanomas are disclosed.Type: GrantFiled: February 27, 2017Date of Patent: August 15, 2023Assignees: FOUNDATION MEDICINE, INC., VANDERBILT UNIVERSITYInventors: Garrett Michael Frampton, Roman Yelensky, James Xin Sun, Douglas Buckner Johnson, Christine Marie Lovly, Jeffrey Alan Sosman, David Fabrizio, Philip James Stephens, Vincent A. Miller
-
Patent number: 11578372Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.Type: GrantFiled: November 14, 2019Date of Patent: February 14, 2023Assignee: Foundation Medicine, Inc.Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
-
Publication number: 20220399131Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.Type: ApplicationFiled: August 10, 2022Publication date: December 15, 2022Applicant: Foundation Medicine, Inc.Inventors: Michael PELLINI, Gary PALMER, Mary Patricia LANCELOTTA, Matthew J. HAWRYLUK, Vincent A. MILLER
-
Patent number: 11450438Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment fType: GrantFiled: September 23, 2019Date of Patent: September 20, 2022Assignee: Foundation Medicine, Inc.Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20220251667Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: February 16, 2022Publication date: August 11, 2022Applicant: Foundation Medicine, Inc.Inventors: Maureen T. CRONIN, Garrett Michael FRAMPTON, Doron LIPSON, Vincent A. MILLER, Gary PALMER, Jeffrey S. ROSS, Philip James STEPHENS, Roman YELENSKY
-
Patent number: 11286532Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: GrantFiled: January 22, 2018Date of Patent: March 29, 2022Assignee: FOUNDATION MEDICINE, INC.Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Publication number: 20210283134Abstract: Methods and compositions for treating cholangiocarcinoma.Type: ApplicationFiled: March 17, 2021Publication date: September 16, 2021Applicant: Foundation Medicine, Inc.Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
-
Patent number: 10980804Abstract: Methods and compositions for treating cholangiocarcinoma.Type: GrantFiled: January 17, 2014Date of Patent: April 20, 2021Assignee: FOUNDATION MEDICINE, INC.Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
-
Publication number: 20200299775Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.Type: ApplicationFiled: November 14, 2019Publication date: September 24, 2020Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
-
Publication number: 20200211679Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment fType: ApplicationFiled: September 23, 2019Publication date: July 2, 2020Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
-
Publication number: 20190233897Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: September 5, 2018Publication date: August 1, 2019Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Publication number: 20180320238Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: ApplicationFiled: January 22, 2018Publication date: November 8, 2018Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
-
Patent number: 10093983Abstract: Novel mutant ESR1 molecules and uses are disclosed.Type: GrantFiled: June 29, 2015Date of Patent: October 9, 2018Assignee: FOUNDATION MEDICINE, INC.Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky